Iron hypothesis and coronary artery disease in geriatric patients

Hossein Mokhtari1, Babak Bagheri2, Mehdi Rasouli1

  • 1Department of Clinical Biochemistry and Immunogenetic Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Mazandaran, Iran.

Insights

Serum ferritin levels are associated with coronary artery disease (CAD) severity and likelihood, though not independently. Further research into iron deficiency and toxicity in CAD is warranted.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Nutritional Science

Background:

  • Iron acts as a pro-oxidant, contributing to the pathogenesis of coronary artery disease (CAD).
  • Understanding the relationship between body iron status and CAD occurrence/severity is crucial.

Purpose of the Study:

  • To investigate the association between body iron status and the occurrence and severity of CAD.
  • To evaluate novel iron indices, such as the serum free iron index, in relation to CAD.

Main Methods:

  • Coronary angiography was used to classify 225 subjects (110 males, 115 females) into CAD cases and controls.
  • Serum iron, total iron-binding capacity (UIBC), transferrin, ferritin, and a newly defined serum free iron index were measured.

Main Results:

  • Serum ferritin levels were significantly higher in CAD patients compared to controls.
  • Serum ferritin showed a significant association with CAD likelihood and severity, but this correlation diminished in the presence of classical risk factors.
  • Serum ferritin demonstrated the highest efficiency in predicting CAD among the assessed iron indices (AUC = 0.61).

Conclusions:

  • Serum ferritin, an indicator of intracellular iron, is significantly associated with CAD, but this relationship is not independent.
  • The "iron hypothesis" in CAD pathogenesis should consider both iron deficiency and iron toxicity, particularly in elderly populations where iron deficiency is common.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
500
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
289
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
399
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
703
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
278